NCT02007252View on ClinicalTrials.gov

ACZ885 for the Treatment of Abdominal Aortic Aneurysm

PHASE2TerminatedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Abdominal Aortic Aneurysm (AAA)
Interventions
DRUG

ACZ885

ACZ885 150 mg liquid pre-filled syringes were administered s.c..

DRUG

Placebo

Matching placebo liquid pre-filled syringes were administered s.c..

Trial Locations (9)

6000

Novartis Investigative Site, Kolding

22903

Novartis Investigative Site, Charlottesville

DK-2100

Novartis Investigative Site, Copenhagen

DK-5000

Novartis Investigative Site, Odense C

Unknown

Novartis Investigative Site, Amsterdam

5623EJ

Novartis Investigative Site, Eindhoven

701 16

Novartis Investigative Site, Örebro

171 76

Novartis Investigative Site, Stockholm

M23 9LT

Novartis Investigative Site, Manchester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY